The Securities Exchange Board of India (Sebi) has asked several pharma companies to submit the details on the public disclosures that influence the stock prices. This comes as several pharma stocks have seen sharp movements and Sebi wants to check if all the price-sensitive information was timely provided to the investors or not, according to a report by Economic Times (ET).
The details that need to be disclosed are new drugs, pending patents, source of raw materials, and new partnerships, among others. In several cases, SEBI has reportedly found that no disclosures were made at all.
"In one case, the